Nagendra Koneru, MD
Radiation Oncology · Maywood, ILNPI 1508989260
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $18,215 of the $29,417 with a category attached, or 61.9%. 20 manufacturers reported payments, led by Novartis at 46.1% of the total. 2025 is the largest year on record at $16,204, more than ten times the $977 reported in 2019. Among radiation oncology clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 91 payments — averaging $323.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$14K
- Siemens Medical Solutions USA, Inc.$9K
- Reflexion Medical, Inc.$3K
- AstraZeneca$2K
- Isoray, Inc$1K
- Elekta, Inc.$460
- plus $1K from 14 others
What the payments were for
- Consulting fees$18,21562%
- Speaking & faculty fees$4,50015%
- Travel & lodging$3,73213%
- Food & beverage$2,7709%
- Education$2001%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 24 | $13,575 |
| Siemens Medical Solutions USA, Inc. | 14 | $8,648 |
| Reflexion Medical, Inc. | 3 | $2,800 |
| AstraZeneca | 1 | $1,890 |
| Isoray, Inc | 11 | $1,010 |
| Elekta, Inc. | 5 | $460 |
| Astellas Pharma US Inc | 7 | $295 |
| Tempus AI, Inc | 6 | $149 |
| Varian Medical Systems, Inc. | 2 | $107 |
| Boston Scientific | 1 | $80 |
| Merck | 4 | $79 |
| GSK | 3 | $62 |
| Novocure Inc. | 2 | $56 |
| Daiichi Sankyo Inc. | 2 | $52 |
| Jazz Pharmaceuticals Inc. | 1 | $39 |
| Progenics Pharmaceuticals, Inc. | 1 | $30 |
| Incyte Corporation | 1 | $29 |
| AbbVie | 1 | $23 |
| Johnson & Johnson | 1 | $18 |
| G1 Therapeutics, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PLUVICTO$10,657
- REFLEXION MEDICAL RADIOTHERAPY SYSTEM$2,800
- IMFINZI$1,890
- Brachytherapy Source$721
- TrueBeam$638
- ELEKTA MEDICAL LINEAR ACCELERATOR$145
How this compares
$29,417 in reported general payments places this provider in the 95th percentile of 242 radiation oncology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 47 | $714 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Maywood
- Abhishek SolankiMaywood$23K
- Matthew HarkenriderMaywood$13K
- James WelshMaywood$9K
- Bahman EmamiMaywood$3K
- Samar KhanMaywood$1K
- Ramji RajendranElk Grove Village$207K
- Brian BaumannSpringfield$204K
- Tamer RefaatFreeport$151K
- Parthiv MehtaGlenview$149K
- Sean PitrodaChicago$103K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.